Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03WWW
|
|||
| Drug Name |
Hepcidin
|
|||
| Indication | Hemochromatosis [ICD-11: 5C64.1Y] | Phase 1 | [1] | |
| Drug Resistance Mutation (DRM) | Top | |||
|---|---|---|---|---|
| DRM | DRM Info | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemia. J Hematol Oncol. 2017 Mar 21;10(1):73. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.